Status:
COMPLETED
The Effect of Glutamine on Systemic Inflammation During Human Experimental Endotoxemia
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Sepsis
Systemic Inflammation
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
Glutamine levels decrease during severe sepsis; this may be associated with increased mortality. The investigators tested the effects of glutamine supplementation on systemic inflammation in a human s...
Detailed Description
Glutamine levels have been shown to decrease substantially with severe sepsis and this has been connected with increased mortality. Therefore, in the present study, we infused either saline or Alanine...
Eligibility Criteria
Inclusion
- Healthy young males
Exclusion
- Any kind of acute or chronic diseases
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00780520
Start Date
June 1 2007
End Date
October 1 2007
Last Update
October 27 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre of Inflammation and Metabolism, Rigshospitalet
Copenhagen, Denmark, DK-2100